Detail akcie FAES FARMA online

Business Summary: Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Financial Summary: BRIEF: For the three months ended 31 March 2022, FAES Farma SA revenues increased 22% to EUR116.2M. Net income increased 24% to EUR26.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Net Financial Result increase from EUR4K (expense) to EUR182K (income). Basic Earnings per Share excluding Extraordinary Items increased from EUR0.07 to EUR0.09.